Chromogranin A and other enteroendocrine markers in inflammatory bowel disease

Sara Massironi, Alessandra Zilli, Federica Cavalcoli, Dario Conte, Maddalena Peracchi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Changes in the distribution and products of enteroendocrine cells may play a role in immune activation and regulation of gut inflammation. This review aims at critically evaluating the main enteroendocrine markers in inflammatory bowel diseases (IBD). A narrative review was performed by searching inflammatory bowel diseases and enteroendocrine biomarkers in PubMed. Relevant modifications of some enteroendocrine markers, such as Chromogranin A, and their correlation with disease activity have been reported in patients with inflammatory bowel diseases. Even if data about neuroendocrine markers are sometimes contrasting, they may be potentially useful for the diagnosis and clinical management of these patients.

Original languageEnglish
Pages (from-to)127-134
Number of pages8
JournalNeuropeptides
Volume58
DOIs
Publication statusPublished - 2016

Fingerprint

Chromogranin A
Inflammatory Bowel Diseases
Enteroendocrine Cells
PubMed
Biomarkers
Inflammation

Keywords

  • Chromogranin A
  • Crohn's disease
  • Enteroendocrine cell
  • Inflammatory bowel disease
  • Ulcerative colitis

ASJC Scopus subject areas

  • Endocrinology
  • Neurology
  • Cellular and Molecular Neuroscience
  • Endocrine and Autonomic Systems

Cite this

Chromogranin A and other enteroendocrine markers in inflammatory bowel disease. / Massironi, Sara; Zilli, Alessandra; Cavalcoli, Federica; Conte, Dario; Peracchi, Maddalena.

In: Neuropeptides, Vol. 58, 2016, p. 127-134.

Research output: Contribution to journalArticle

Massironi, Sara ; Zilli, Alessandra ; Cavalcoli, Federica ; Conte, Dario ; Peracchi, Maddalena. / Chromogranin A and other enteroendocrine markers in inflammatory bowel disease. In: Neuropeptides. 2016 ; Vol. 58. pp. 127-134.
@article{721fb9cd786a4bbc8fe9a3f33fb39940,
title = "Chromogranin A and other enteroendocrine markers in inflammatory bowel disease",
abstract = "Changes in the distribution and products of enteroendocrine cells may play a role in immune activation and regulation of gut inflammation. This review aims at critically evaluating the main enteroendocrine markers in inflammatory bowel diseases (IBD). A narrative review was performed by searching inflammatory bowel diseases and enteroendocrine biomarkers in PubMed. Relevant modifications of some enteroendocrine markers, such as Chromogranin A, and their correlation with disease activity have been reported in patients with inflammatory bowel diseases. Even if data about neuroendocrine markers are sometimes contrasting, they may be potentially useful for the diagnosis and clinical management of these patients.",
keywords = "Chromogranin A, Crohn's disease, Enteroendocrine cell, Inflammatory bowel disease, Ulcerative colitis",
author = "Sara Massironi and Alessandra Zilli and Federica Cavalcoli and Dario Conte and Maddalena Peracchi",
year = "2016",
doi = "10.1016/j.npep.2016.01.002",
language = "English",
volume = "58",
pages = "127--134",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Chromogranin A and other enteroendocrine markers in inflammatory bowel disease

AU - Massironi, Sara

AU - Zilli, Alessandra

AU - Cavalcoli, Federica

AU - Conte, Dario

AU - Peracchi, Maddalena

PY - 2016

Y1 - 2016

N2 - Changes in the distribution and products of enteroendocrine cells may play a role in immune activation and regulation of gut inflammation. This review aims at critically evaluating the main enteroendocrine markers in inflammatory bowel diseases (IBD). A narrative review was performed by searching inflammatory bowel diseases and enteroendocrine biomarkers in PubMed. Relevant modifications of some enteroendocrine markers, such as Chromogranin A, and their correlation with disease activity have been reported in patients with inflammatory bowel diseases. Even if data about neuroendocrine markers are sometimes contrasting, they may be potentially useful for the diagnosis and clinical management of these patients.

AB - Changes in the distribution and products of enteroendocrine cells may play a role in immune activation and regulation of gut inflammation. This review aims at critically evaluating the main enteroendocrine markers in inflammatory bowel diseases (IBD). A narrative review was performed by searching inflammatory bowel diseases and enteroendocrine biomarkers in PubMed. Relevant modifications of some enteroendocrine markers, such as Chromogranin A, and their correlation with disease activity have been reported in patients with inflammatory bowel diseases. Even if data about neuroendocrine markers are sometimes contrasting, they may be potentially useful for the diagnosis and clinical management of these patients.

KW - Chromogranin A

KW - Crohn's disease

KW - Enteroendocrine cell

KW - Inflammatory bowel disease

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84956948909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956948909&partnerID=8YFLogxK

U2 - 10.1016/j.npep.2016.01.002

DO - 10.1016/j.npep.2016.01.002

M3 - Article

VL - 58

SP - 127

EP - 134

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

ER -